Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 204 results found. Search for [ bharat biotech's covaxin ]

Results 80 to 100 of 204
BusinessToday.In
January 4, 2021
The phase-2 trials of Zydus Cadila's coronavirus vaccine had been conducted in around 1,000 healthy adults


BusinessToday.In
January 4, 2021
Union Health Minister Dr Harsh Vardhan slammed senior Congress party leaders Shashi Tharoor and Jairam Ramesh, and Samajwadi Party leader Akhilesh Yadav for politicising the 'critical issue'


BusinessToday.In
January 3, 2021
The ICMR head emphasised that the scientists at ICMR have been successfully able to culture the UK strain and the efficacy of Covaxin against it will be further tested in days to come


BusinessToday.In
January 3, 2021
Calling it a great day for the country, AIIMS Director Dr Randeep Guleria said that initially Serum-AstraZeneca's Covishield will be administered to the people


Reuters
January 3, 2021
India on Sunday granted emergency approval to Bharat Biotech's COVAXIN but faced questions after taking the step without publishing efficacy data for the homegrown coronavirus vaccine


BusinessToday.In
January 3, 2021
Two leading vaccine contenders in India have been granted approval for restricted use in the country. Check out how netizens reacted to the news of the vaccines getting approved


BusinessToday.In
January 3, 2021
PM Modi thanked doctors, medical staff, police personnel, sanitation workers and all corona warriors for their hard work during the coronavirus outbreak


BusinessToday.In
January 3, 2021
COVID-19 vaccine in India: It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, said PM Modi


BusinessToday.In
January 3, 2021
COVID-19 vaccines in India: Oxford-AstraZeneca's coronavirus vaccine Covishield and Bharat Biotech's COVID vaccine Covaxin will be India's first vaccines


PTI
January 3, 2021
The research body said vero cell lines were used by the scientists of ICMR-NIV to culture the UK-variant of the virus


BusinessToday.In
January 3, 2021
Coronavirus vaccine trials: Bharat Biotech said that it is steadily moving towards its goal of 26,000 volunteers. Phase 3 of human clinical trials for Covaxin began in mid-November


Reuters
January 3, 2021
COVID-19 vaccine: The ministry added that the doctor has a history of allergic reactions and said that there is no evidence from clinical trials that anyone has developed an inflammation of the brain after the vaccine's application


BusinessToday.In
January 2, 2021
The SEC has recommended Covaxin for emergency use authorisation; the recommendation, along with rollout modalities, will now be taken up by the DCGI for a final decision on the matter


BusinessToday.In
January 2, 2021
Experts will review the indigenously developed vaccine a day after the Subject Expert Committee (SEC) had recommended Serum-Oxford's Covishield COVID-19 vaccine to the Drugs Controller General of India (DCGI) for emergency use authorisation


BusinessToday.In
January 1, 2021
Covishield has become the first coronavirus vaccine to receive a regulatory nod in India. Now, Drug Controller General of India (DCGI) will take a final call on rolling out the inoculation


BusinessToday.In
January 1, 2021
CDSCO's expert panel has recommended the Serum Institute of India's Covishield COVID-19 vaccine for emergency use authorisation to DCGI


BusinessToday.In
January 1, 2021
Reports suggest that an expert panel will meet to take up the application for emergency use of the three vaccines


BusinessToday.In
December 29, 2020
Poonawalla says Covishield shows efficacy level of 95 per cent provided two shots are taken after a gap of 2-3 months; AstraZeneca will make that public with documentation soon, he adds


BusinessToday.In
December 29, 2020
The chief executive of Serum Institute - the biggest vaccine maker in the world by volume - said all trial data for Covishield has been provided to authorities in the UK and India as \"nobody wants to risk safety\"


Reuters
December 27, 2020
Coronavirus vaccine: Russia launched a voluntary vaccination programme with the Russia-made Sputnik V vaccine earlier in December, starting with the most vulnerable groups in Moscow


PAGES 5 OF 11  12345